Related Experiment Video
Updated: Jun 19, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
NEUTRALIZING ANTIBODIES IN ABORTIVE POLIOMYELITIS
1Departments of Pediatrics and Medicine, Yale University School of Medicine, New Haven.
Abstract:
The neutralizing antibody content for poliomyelitis virus has been tested with both a human and a passage strain of the virus in serial samples of sera from five mild cases of abortive poliomyelitis, and an increase in this antibody content has been demonstrated in convalescent samples obtained within 4 weeks of the acute illness.
Insights
Researchers measured neutralizing antibodies against poliomyelitis virus in mild polio cases. Antibody levels increased in patients within four weeks of their acute illness.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Poliomyelitis, a viral disease, can cause paralysis.
- Understanding the immune response is crucial for disease management.
Purpose of the Study:
- To quantify neutralizing antibody levels against poliovirus in mild abortive poliomyelitis cases.
- To determine if antibody levels change during the course of the illness.
Main Methods:
- Sera samples were collected from five patients with mild abortive poliomyelitis.
- Neutralizing antibody content against human and passage strains of poliovirus was measured.
- Serial samples were analyzed to track antibody changes over time.
Main Results:
- An increase in neutralizing antibody content was observed in the sera.
- This increase was evident in convalescent samples collected within four weeks of the acute illness.
Conclusions:
- Mild abortive poliomyelitis elicits a detectable increase in poliovirus-neutralizing antibodies.
- The findings contribute to understanding the humoral immune response to poliovirus infection.
Related Concept Videos
Poliomyelitis
Botulism
Respiratory Syncytial Virus Disease
Cross-reactivity
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Inhibitors of Virion Maturation and Assembly

